Moore N - Search Results

1

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA, Lassalle R, Marit G, Reiffers J, Begaud B, Moore N, Molimard M, Mahon FX. Picard S, et al. Among authors: moore n. Blood. 2007 Apr 15;109(8):3496-9. doi: 10.1182/blood-2006-07-036012. Epub 2006 Dec 27. Blood. 2007. PMID: 17192396 Free article. Clinical Trial.

2

Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?

Molimard M, Moore N, Begaud B. Molimard M, et al. Among authors: moore n. Lancet. 1998 Jan 3;351(9095):66-7. doi: 10.1016/S0140-6736(05)78055-7. Lancet. 1998. PMID: 9433446 No abstract available.

3

Is reporting rate a good predictor of risks associated with drugs?

Pierfitte C, Bégaud B, Lagnaoui R, Moore ND. Pierfitte C, et al. Among authors: moore nd. Br J Clin Pharmacol. 1999 Mar;47(3):329-31. doi: 10.1046/j.1365-2125.1999.00881.x. Br J Clin Pharmacol. 1999. PMID: 10215758 Free PMC article.

4

The link between sunshine and phototoxicity of sparfloxacin.

Pierfitte C, Royer RJ, Moore N, Bégaud B. Pierfitte C, et al. Among authors: moore n. Br J Clin Pharmacol. 2000 Jun;49(6):609-12. doi: 10.1046/j.1365-2125.2000.00212.x. Br J Clin Pharmacol. 2000. PMID: 10848726 Free PMC article.

5

Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.

Moore N, Verschuren X, Montout C, Callens J, Kong SX, Bégaud B. Moore N, et al. Therapie. 2000 Jan-Feb;55(1):133-6. Therapie. 2000. PMID: 10860014

6

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Eur J Clin Pharmacol. 2000 May;56(2):181-6. doi: 10.1007/s002280050738. Eur J Clin Pharmacol. 2000. PMID: 10877014

7

Benzodiazepines and hip fractures in elderly people: case-control study.

Pierfitte C, Macouillard G, Thicoïpe M, Chaslerie A, Pehourcq F, Aïssou M, Martinez B, Lagnaoui R, Fourrier A, Bégaud B, Dangoumau J, Moore N. Pierfitte C, et al. Among authors: moore n. BMJ. 2001 Mar 24;322(7288):704-8. doi: 10.1136/bmj.322.7288.704. BMJ. 2001. PMID: 11264208 Free PMC article.

8

Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.

Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Bégaud B. Moore N, et al. Clin Pharmacol Ther. 2001 Jun;69(6):445-50. doi: 10.1067/mcp.2001.116147. Clin Pharmacol Ther. 2001. PMID: 11406742

9

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Among authors: moore n. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660

10

Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.

Lagnaoui R, Moore N, Longy-Boursier M, Baumevieille M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):531-5. doi: 10.1002/pds.621. Pharmacoepidemiol Drug Saf. 2001. PMID: 11828836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,560 results

Search Page